Total Payments
$2,429
2024 Payments
$32.08
Companies
23
Transactions
226
Medicare Patients
828
Medicare Billing
$113,827
Payment Breakdown by Category
Food & Beverage$2,413 (99.3%)
Education$16.66 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,413 | 223 | 99.3% |
| Education | $16.66 | 3 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $323.70 | 49 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $311.18 | 22 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $289.36 | 16 | $0 (2018) |
| Lilly USA, LLC | $216.93 | 22 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $213.45 | 22 | $0 (2017) |
| Novo Nordisk Inc | $159.18 | 23 | $0 (2018) |
| Valeritas, Inc. | $110.64 | 6 | $0 (2017) |
| Takeda Pharmaceuticals America, Inc. | $96.33 | 14 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $95.94 | 7 | $0 (2018) |
| GlaxoSmithKline, LLC. | $89.21 | 7 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $32.08 | 1 | ABBVIE INC. ($32.08) |
| 2018 | $635.20 | 55 | Boehringer Ingelheim Pharmaceuticals, Inc. ($150.36) |
| 2017 | $1,762 | 170 | AstraZeneca Pharmaceuticals LP ($223.47) |
All Payment Transactions
226 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/26/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $32.08 | General |
| Category: NEUROSCIENCE | ||||||
| 05/31/2018 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $1.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/24/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/24/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $3.58 | General |
| Category: Central Nervous System (CNS) | ||||||
| 05/23/2018 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Vascepa | Food and Beverage | Cash or cash equivalent | $12.81 | General |
| Category: Cardiovascular | ||||||
| 05/21/2018 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: DIABETES | ||||||
| 05/17/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: DIABETES | ||||||
| 05/17/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.86 | General |
| Category: NEUROSCIENCE | ||||||
| 05/14/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $10.79 | General |
| Category: Diabetes | ||||||
| 05/10/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $97.78 | General |
| Category: DIABETES | ||||||
| 05/07/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Dexilant (Drug) | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: Upper GI | ||||||
| 05/07/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $1.08 | General |
| Category: Lower GI | ||||||
| 05/03/2018 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/02/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: NEUROSCIENCE | ||||||
| 05/01/2018 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: Endocrinology | ||||||
| 04/24/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: DIABETES | ||||||
| 04/12/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Dexilant (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Upper GI | ||||||
| 04/12/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Dexilant (Drug) | Food and Beverage | In-kind items and services | $1.83 | General |
| Category: Upper GI | ||||||
| 04/10/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/09/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: UROLOGY | ||||||
| 04/05/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.51 | General |
| Category: NEUROSCIENCE | ||||||
| 04/02/2018 | Allergan Inc. | BYSTOLIC (Drug) | Food and Beverage | In-kind items and services | $9.57 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/28/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $10.49 | General |
| Category: Gastroenterology | ||||||
| 03/27/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: Cardiology | ||||||
| 03/23/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 113 | 318 | $52,644 | $21,164 |
| 2022 | 4 | 162 | 398 | $66,722 | $26,166 |
| 2021 | 4 | 219 | 519 | $87,893 | $32,510 |
| 2020 | 6 | 334 | 682 | $129,398 | $33,986 |
Total Patients
828
Total Services
1,917
Medicare Billing
$113,827
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 98 | 298 | $48,294 | $19,009 | 39.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 20 | $4,350 | $2,155 | 49.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 111 | 339 | $53,518 | $21,293 | 39.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 11 | 13 | $6,604 | $1,965 | 29.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 14 | $3,150 | $1,510 | 47.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 32 | $3,450 | $1,398 | 40.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 137 | 398 | $67,442 | $24,879 | 36.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 59 | 95 | $11,351 | $4,204 | 37.0% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 11 | 13 | $6,500 | $2,025 | 31.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 12 | 13 | $2,600 | $1,402 | 53.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 148 | 388 | $75,468 | $20,593 | 27.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 68 | 127 | $18,615 | $5,314 | 28.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 64 | 82 | $24,737 | $4,052 | 16.4% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2020 | 13 | 15 | $4,788 | $1,939 | 40.5% |
| G0179 | Physician re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial imp | Office | 2020 | 24 | 50 | $3,650 | $1,435 | 39.3% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 17 | 20 | $2,140 | $653.56 | 30.5% |
About Dr. Kemmely Hochstetler, M.D
Dr. Kemmely Hochstetler, M.D is a Family Medicine healthcare provider based in Wheelersburg, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1992993638.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kemmely Hochstetler, M.D has received a total of $2,429 in payments from pharmaceutical and medical device companies, with $32.08 received in 2024. These payments were reported across 226 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,413).
As a Medicare-enrolled provider, Hochstetler has provided services to 828 Medicare beneficiaries, totaling 1,917 services with total Medicare billing of $113,827. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Wheelersburg, OH
- Active Since 10/09/2007
- Last Updated 12/22/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1992993638
Products in Payments
- JARDIANCE (Drug) $233.01
- VRAYLAR (Drug) $208.09
- TRULICITY (Drug) $164.90
- FARXIGA (Drug) $151.61
- BEVESPI AEROSPHERE (Drug) $137.75
- JANUVIA (Drug) $119.41
- V-GO (Device) $110.64
- Victoza (Drug) $98.19
- Trintellix (Drug) $93.76
- Ranexa (Drug) $84.06
- BELSOMRA (Drug) $73.52
- Trulance (Drug) $63.98
- ANORO (Drug) $63.28
- STIOLTO (Drug) $62.91
- TRADJENTA (Drug) $50.87
- XARELTO (Drug) $47.58
- Prolastin-C (Biological) $46.68
- LINZESS (Drug) $46.43
- SOLIQUA (Drug) $42.60
- Dexilant (Drug) $40.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Wheelersburg
Mr. James Mcginnis, Do, DO
Family Medicine — Payments: $19,090
Family Medicine $19,090
Dr. David Provaznik, Do, DO
Family Medicine — Payments: $10,348
Family Medicine $10,348
Jerod Walker, Do, DO
Family Medicine — Payments: $8,192
Family Medicine $8,192
Zachary Underwood, Do, DO
Family Medicine — Payments: $6,464
Family Medicine $6,464
Dr. J Hernandez, Md, MD
Family Medicine
Family Medicine